- Special Projects
Stephanie Deegan is one of many patients who cannot get opioids as easily, but she still needs help for severe pain.
E-cigarette companies have an incentive to prove their product is safe.
Other pain treatments have proven effective, so why should they cost more?
Doctors and hospitals work off a rating system. Why can’t rehabilitation programs?
In Hawaii, most patients have limited choices of where they can go for medical treatment and they’re unlikely to choose hospitals based on posted costs.
If they don’t participate in your insurance plan, medical providers can charge whatever they want. It’s time for some limits on that.
Not only do patients have no idea about the actual prices of their prescriptions, but their doctors don’t either.
Brand-name pharmaceutical companies are convincing consumers to keep using products that cost insurance companies far more than generic equivalents.
New products approved by the Food and Drug Administration can make a lot of money. Maybe the cash-strapped agency should get a percentage.
Put the money toward research, treatment and finding ways to better the health of everyone, the same as we did with tobacco settlements.
All of the choices now available to Medicare recipients could live on, even in a single-payer system.
The U.S. government and pharmaceutical companies can’t seem to solve the problem, but some creative work-arounds are taking shape.